Literature DB >> 25473049

Regulatory T cells resist virus infection-induced apoptosis.

Jenny W Che1, Anke R M Kraft1, Liisa K Selin1, Raymond M Welsh2.   

Abstract

UNLABELLED: Regulatory T (Treg) cells are important in the maintenance of self-tolerance, and the depletion of Treg cells correlates with autoimmune development. It has been shown that type I interferon (IFN) responses induced early in the infection of mice can drive memory (CD44hi) CD8 and CD4 T cells into apoptosis, and we questioned here whether the apoptosis of CD44-expressing Treg cells might be involved in the infection-associated autoimmune development. Instead, we found that Treg cells were much more resistant to apoptosis than CD44hi CD8 and CD4 T cells at days 2 to 3 after lymphocytic choriomeningitis virus infection, when type I IFN levels are high. The infection caused a downregulation of the interleukin-7 (IL-7) receptor, needed for survival of conventional T cells, while increasing on Treg cells the expression of the high-affinity IL-2 receptor, needed for STAT5-dependent survival of Treg cells. The stably maintained Treg cells early during infection may explain the relatively low incidence of autoimmune manifestations among infected patients. IMPORTANCE: Autoimmune diseases are controlled in part by regulatory T cells (Treg) and are thought to sometimes be initiated by viral infections. We tested the hypothesis that Treg may die off at early stages of infection, when virus-induced factors kill other lymphocyte types. Instead, we found that Treg resisted this cell death, perhaps reducing the tendency of viral infections to cause immune dysfunction and induce autoimmunity.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25473049      PMCID: PMC4338871          DOI: 10.1128/JVI.02245-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  CD4(+) T regulatory cells are more resistant to DNA damage compared to CD4(+) T effector cells as revealed by flow cytometric analysis.

Authors:  Claudia Winzler; Margherita Fantinato; Marco Giordan; Elisabetta Calore; Giuseppe Basso; Chiara Messina
Journal:  Cytometry A       Date:  2011-08-30       Impact factor: 4.355

2.  Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival.

Authors:  Timothy W Hand; Weiguo Cui; Yong Woo Jung; Esen Sefik; Nikhil S Joshi; Anmol Chandele; Ying Liu; Susan M Kaech
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205

3.  STAT5 is critical to maintain effector CD8+ T cell responses.

Authors:  Pulak Tripathi; Sema Kurtulus; Sara Wojciechowski; Allyson Sholl; Kasper Hoebe; Suzanne C Morris; Fred D Finkelman; H Leighton Grimes; David A Hildeman
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

4.  An in vivo IL-7 requirement for peripheral Foxp3+ regulatory T cell homeostasis.

Authors:  Grace Y Kim; Davinna L Ligons; Changwan Hong; Megan A Luckey; Hilary R Keller; Xuguang Tai; Philip J Lucas; Ronald E Gress; Jung-Hyun Park
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

5.  Type I interferons maintain Foxp3 expression and T-regulatory cell functions under inflammatory conditions in mice.

Authors:  Shee Eun Lee; Xiangli Li; Joanna C K Kim; Jongdae Lee; Jose M González-Navajas; Seol Hee Hong; In-Kyu Park; Joon Haeng Rhee; Eyal Raz
Journal:  Gastroenterology       Date:  2012-04-01       Impact factor: 22.682

6.  High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation.

Authors:  Christopher Sjöwall; Kristina Cardell; Elisabeth A Boström; Maria I Bokarewa; Helena Enocsson; Mattias Ekstedt; Liselott Lindvall; Aril Frydén; Sven Almer
Journal:  Hum Immunol       Date:  2012-02-01       Impact factor: 2.850

7.  Clinical Sindbis alphavirus infection is associated with HLA-DRB1*01 allele and production of autoantibodies.

Authors:  Jussi Sane; Satu Kurkela; Marja-Liisa Lokki; Aaro Miettinen; Tapani Helve; Antti Vaheri; Olli Vapalahti
Journal:  Clin Infect Dis       Date:  2012-04-20       Impact factor: 9.079

8.  PC61 (anti-CD25) treatment inhibits influenza A virus-expanded regulatory T cells and severe lung pathology during a subsequent heterologous lymphocytic choriomeningitis virus infection.

Authors:  Anke R M Kraft; Myriam F Wlodarczyk; Laurie L Kenney; Liisa K Selin
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

9.  On the role of regulatory T cells during viral-induced inflammatory lesions.

Authors:  Tamara Veiga-Parga; Amol Suryawanshi; Sachin Mulik; Fernanda Giménez; Shalini Sharma; Tim Sparwasser; Barry T Rouse
Journal:  J Immunol       Date:  2012-11-05       Impact factor: 5.422

10.  Antigen-specific memory regulatory CD4+Foxp3+ T cells control memory responses to influenza virus infection.

Authors:  Erik L Brincks; Alan D Roberts; Tres Cookenham; Stewart Sell; Jacob E Kohlmeier; Marcia A Blackman; David L Woodland
Journal:  J Immunol       Date:  2013-03-06       Impact factor: 5.422

View more
  8 in total

1.  CD70, a novel target of CAR T-cell therapy for gliomas.

Authors:  Linchun Jin; Haitao Ge; Yu Long; Changlin Yang; Yifan Emily Chang; Luyan Mu; Elias J Sayour; Gabriel De Leon; Qiong J Wang; James C Yang; Paul S Kubilis; Hongbo Bao; Songsong Xia; Dunyue Lu; Yingjun Kong; Li Hu; Yujiao Shang; Chencheng Jiang; Jing Nie; Shimin Li; Yunhe Gu; Jiahang Sun; Duane A Mitchell; Zhiguo Lin; Jianping Huang
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300

2.  Dynamic Immune Landscape and VZV-Specific T Cell Responses in Patients With Herpes Zoster and Postherpetic Neuralgia.

Authors:  Qiao Peng; Xuejiao Guo; Yang Luo; Guocan Wang; Lingyu Zhong; Jiamin Zhu; Yunze Li; Xun Zeng; Zhiying Feng
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

3.  Virus-induced natural killer cell lysis of T cell subsets.

Authors:  Keith A Daniels; Carey L O'Donnell; Catherine Castonguay; Tara M Strutt; K Kai McKinstry; Susan L Swain; Raymond M Welsh
Journal:  Virology       Date:  2019-10-18       Impact factor: 3.616

Review 4.  Disease-promoting effects of type I interferons in viral, bacterial, and coinfections.

Authors:  Sophia Davidson; Mala K Maini; Andreas Wack
Journal:  J Interferon Cytokine Res       Date:  2015-02-25       Impact factor: 2.607

Review 5.  Sustained IFN-I Expression during Established Persistent Viral Infection: A "Bad Seed" for Protective Immunity.

Authors:  Xavier Dagenais-Lussier; Hamza Loucif; Armstrong Murira; Xavier Laulhé; Simona Stäger; Alain Lamarre; Julien van Grevenynghe
Journal:  Viruses       Date:  2017-12-30       Impact factor: 5.048

Review 6.  Microbes and Viruses Are Bugging the Gut in Celiac Disease. Are They Friends or Foes?

Authors:  Aaron Lerner; Marina Arleevskaya; Andreas Schmiedl; Torsten Matthias
Journal:  Front Microbiol       Date:  2017-08-02       Impact factor: 5.640

7.  Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8+ T cell epitope.

Authors:  InYoung Song; Anna Gil; Rabinarayan Mishra; Dario Ghersi; Liisa K Selin; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2017-02-27       Impact factor: 15.369

8.  Role of Aryl Hydrocarbon Receptor (AhR) in the Regulation of Immunity and Immunopathology During Trypanosoma cruzi Infection.

Authors:  Laura Fernanda Ambrosio; Constanza Insfran; Ximena Volpini; Eva Acosta Rodriguez; Horacio Marcelo Serra; Francisco J Quintana; Laura Cervi; Claudia Cristina Motrán
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.